Clinical trial
Study on the Tolerability of Duloxetine in Depressed Patients With Parkinson's…
NCT00437125 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00437125 |
|---|---|
| Title | Study on the Tolerability of Duloxetine in Depressed Patients With Parkinson's Disease |
| Official title | An Open Label Pilot Study on the Tolerability of Duloxetine in the Treatment of Depressed Patients With Parkinson's Disease |
| Lead sponsor | Eli Lilly and Company, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Major Depressive Disorder, Idiopathic Parkinson Disease |
| Intervention type | Drug |
| Interventions | Duloxetine hydrochloride |
| Enrollment | 151 |
| Start date | Mar 1, 2007 |
| Primary completion | Jul 1, 2009 |
| Completion | Jul 1, 2009 |
| First posted | Feb 19, 2007 |
| Last update posted | Sep 8, 2010 |
| Countries | Italy |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: